title: Clinical pathways in chronic lymphocytic leukemia: Challenges and solutions.
authors.affiliation: Cardinal Health Specialty Solutions, Cardinal Health, Inc, Dublin, Ohio.
authors.forename: Chadi
authors.initials: C
authors.lastname: Nabhan
authors.affiliation: University of Pennsylvania, Philadelphia, Pennsylvania.
authors.forename: Anthony R
authors.initials: AR
authors.lastname: Mato
authors.affiliation: Cardinal Health Specialty Solutions, Cardinal Health, Inc, Dublin, Ohio.
authors.forename: Bruce A
authors.initials: BA
authors.lastname: Feinberg
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D009363:Neoplasm Proteins / Q000378:metabolism*; D011947:Receptors, Antigen, B-Cell / Q000378:metabolism*; D000069283:Rituximab / Q000627:therapeutic use*; D015398:Signal Transduction / Q000187:drug effects*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D009363:Neoplasm Proteins; D011947:Receptors, Antigen, B-Cell; D000069283:Rituximab; C543332:obinutuzumab